{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T16:33:05Z","timestamp":1788798785827,"version":"build-2803163510"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,26]]},"DOI":"10.7759\/cureus.56944","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T11:24:48Z","timestamp":1711452288000},"source":"Crossref","is-referenced-by-count":1,"title":["Flow Cytometric Assessment of CD26-Positive Leukemic Stem Cells: A Rapid and Valuable Tool in the Diagnosis and Follow-Up of Chronic Myeloid Leukemia"],"prefix":"10.7759","author":[{"given":"Sreerag","family":"Kana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debdatta","family":"Basu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakhee","family":"Kar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Nachiappa Ganesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biswajit","family":"Dubashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199907153410306","article-title":"The biology of chronic myeloid leukemia","volume":"341","author":"Faderl S","year":"1999","unstructured":"Faderl S, Talpaz M, Estrov Z, O'Brien S, Kurzrock R, Kantarjian HM. The biology of chronic myeloid leukemia. N Engl J Med. 1999, 341:164-72. 10.1056\/NEJM199907153410306","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062867","article-title":"Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia","volume":"355","author":"Druker BJ","year":"2006","unstructured":"Druker BJ, Guilhot F, O'Brien SG, et al.. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med. 2006, 355:2408-17. 10.1056\/NEJMoa062867","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-1988","article-title":"Deep molecular response in chronic myeloid leukemia: The new goal of therapy?","volume":"20","author":"Mahon FX","year":"2014","unstructured":"Mahon FX, Etienne G. Deep molecular response in chronic myeloid leukemia: The new goal of therapy?. Clin Cancer Res. 2014, 20:310-22. 10.1158\/1078-0432.CCR-13-1988","journal-title":"Clin Cancer Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/10245330500234195","article-title":"Evolving molecular therapy for chronic myeloid leukaemia--are we on target?","volume":"10","author":"Copland M","year":"2005","unstructured":"Copland M, J\u00f8rgensen HG, Holyoake TL. Evolving molecular therapy for chronic myeloid leukaemia--are we on target?. Hematology. 2005, 10:349-59. 10.1080\/10245330500234195","journal-title":"Hematology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-10-536078","article-title":"Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia","volume":"123","author":"Herrmann H","year":"2014","unstructured":"Herrmann H, Sadovnik I, Cerny-Reiterer S, et al.. Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia. Blood. 2014, 123:3951-62. 10.1182\/blood-2013-10-536078","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/eci.12368","article-title":"DPPIV (CD26) as a novel stem cell marker in Ph+ chronic myeloid leukaemia","volume":"44","author":"Valent P","year":"2014","unstructured":"Valent P, Sadovnik I, R\u00e1\u010dil Z, et al.. DPPIV (CD26) as a novel stem cell marker in Ph+ chronic myeloid leukaemia. Eur J Clin Invest. 2014, 44:1239-45. 10.1111\/eci.12368","journal-title":"Eur J Clin Invest"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-023-01929-6","article-title":"Genetic separation of chronic myeloid leukemia stem cells from normal hematopoietic stem cells at single-cell resolution","volume":"37","author":"Chen Y","year":"2023","unstructured":"Chen Y, M\u00f6bius S, Riege K, Hoffmann S, Hochhaus A, Ernst T, Rudolph KL. Genetic separation of chronic myeloid leukemia stem cells from normal hematopoietic stem cells at single-cell resolution. Leukemia. 2023, 37:1561-6. 10.1038\/s41375-023-01929-6","journal-title":"Leukemia"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00194","article-title":"Residual peripheral blood CD26(+) leukemic stem cells in chronic myeloid leukemia patients during TKI therapy and during treatment-free remission","volume":"8","author":"Bocchia M","year":"2018","unstructured":"Bocchia M, Sicuranza A, Abruzzese E, et al.. Residual peripheral blood CD26(+) leukemic stem cells in chronic myeloid leukemia patients during TKI therapy and during treatment-free remission. Front Oncol. 2018, 8:194. 10.3389\/fonc.2018.00194","journal-title":"Front Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1194712","article-title":"Prospective monitoring of chronic myeloid leukemia patients from the time of TKI discontinuation: The fate of peripheral blood CD26(+) leukemia stem cells","volume":"14","author":"Pacelli P","year":"2023","unstructured":"Pacelli P, Santoni A, Sicuranza A, et al.. Prospective monitoring of chronic myeloid leukemia patients from the time of TKI discontinuation: The fate of peripheral blood CD26(+) leukemia stem cells. Front Pharmacol. 2023, 14:1194712. 10.3389\/fphar.2023.1194712","journal-title":"Front Pharmacol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.9108","article-title":"Quantitative assessment of the CD26+ leukemic stem cell compartment in chronic myeloid leukemia: Patient-subgroups, prognostic impact, and technical aspects","volume":"7","author":"Culen M","year":"2016","unstructured":"Culen M, Borsky M, Nemethova V, et al.. Quantitative assessment of the CD26+ leukemic stem cell compartment in chronic myeloid leukemia: Patient-subgroups, prognostic impact, and technical aspects. Oncotarget. 2016, 7:33016-24. 10.18632\/oncotarget.9108","journal-title":"Oncotarget"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.13826","article-title":"CD26 expression on circulating CD34+\/CD38- progenitor population is a specific and reliable tool for the rapid flow cytometric diagnosis of chronic myeloid leukemia-A single-center validation study","volume":"44","author":"Rahman K","year":"2022","unstructured":"Rahman K, Singh MK, Chandra D, et al.. CD26 expression on circulating CD34+\/CD38- progenitor population is a specific and reliable tool for the rapid flow cytometric diagnosis of chronic myeloid leukemia-A single-center validation study. Int J Lab Hematol. 2022, 44:524-30. 10.1111\/ijlh.13826","journal-title":"Int J Lab Hematol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21764","article-title":"Flow cytometry assessment of CD26(+) leukemic stem cells in peripheral blood: A simple and rapid new diagnostic tool for chronic myeloid leukemia","volume":"96","author":"Raspadori D","year":"2019","unstructured":"Raspadori D, Pacelli P, Sicuranza A, et al.. Flow cytometry assessment of CD26(+) leukemic stem cells in peripheral blood: A simple and rapid new diagnostic tool for chronic myeloid leukemia. Cytometry B Clin Cytom. 2019, 96:294-9. 10.1002\/cyto.b.21764","journal-title":"Cytometry B Clin Cytom"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.13807","article-title":"Identification of peripheral blood CD26+ leukemic stem cells has a potential role in the rapid diagnosis of chronic myeloid leukemia","volume":"44","author":"Sharma P","year":"2022","unstructured":"Sharma P, Sachdeva MU, Naseem S, Sreedharanunni S, Das R, Malhotra P, Varma N. Identification of peripheral blood CD26+ leukemic stem cells has a potential role in the rapid diagnosis of chronic myeloid leukemia. Int J Lab Hematol. 2022, 44:518-23. 10.1111\/ijlh.13807","journal-title":"Int J Lab Hematol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.lrr.2022.100321","article-title":"Peripheral blood CD26 positive leukemic stem cells as a possible diagnostic and prognostic marker in chronic myeloid leukemia","volume":"17","author":"Ebian HF","year":"2022","unstructured":"Ebian HF, Abdelnabi AM, Abdelazem AS, Khamis T, Fawzy HM, Hussein S. Peripheral blood CD26 positive leukemic stem cells as a possible diagnostic and prognostic marker in chronic myeloid leukemia. Leuk Res Rep. 2022, 17:100321. 10.1016\/j.lrr.2022.100321","journal-title":"Leuk Res Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/235014-flow-cytometric-assessment-of-cd26-positive-leukemic-stem-cells-a-rapid-and-valuable-tool-in-the-diagnosis-and-follow-up-of-chronic-myeloid-leukemia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T11:24:51Z","timestamp":1711452291000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/235014-flow-cytometric-assessment-of-cd26-positive-leukemic-stem-cells-a-rapid-and-valuable-tool-in-the-diagnosis-and-follow-up-of-chronic-myeloid-leukemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,26]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.56944","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,26]]}}}